Ignite Creation Date:
2024-05-06 @ 3:26 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04639986
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-14
First Post:
2020-11-17
Brief Title:
Asian Study of Sacituzumab Govitecan IMMU-132 in HRHER2- Metastatic Breast Cancer MBC
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Organization Data
Organization:
Gilead Sciences
Class:
INDUSTRY
Study ID:
EVER-132-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gilead Sciences
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None